Chair & CEO at Eli Lilly and Company
I chair and run Eli Lilly, steering a 150-year-old drug maker toward the next diseases. My job is choosing where to aim research, how much risk to take, and balancing investors with patients waiting for treatments. Right now that means guiding the GLP-1 surge and rebuilding our science with large-scale computing.
This answer is part of a full interview with Dave Ricks, Chair & CEO at Eli Lilly and Company.
Found this insight valuable? Share it with your network to help others learn from Dave Ricks's experience.
Use this answer in your research, article, or academic work
